Biogen Idec Leverages Up For $3 Billion Share Buyback Plan (BIIB)
Biogen Idec inc. (BIIB-NASDAQ) is trading up roughly 4% pre-market at $51.40, within striking distance of its $52.72 high over the last year on news of a share buyback plan. ...Read Full Story »

